Sibel Bahtiri
PhD candidate
- Name
- S. Bahtiri MSc
- Telephone
- 071 5275706
- s.bahtiri@lacdr.leidenuniv.nl
- ORCID iD
- 0009-0000-4111-0634
ᅟ
PhD candidate
- Faculty of Science
- Leiden Academic Centre for Drug Research
- LACDR/Toxicology
- Bahtiri S., Hagens T.M.S., Water B. van de & Niemeijer M.C. (2025), Mechanism-based drug safety testing using innovative in vitro liver models: from DILI prediction to idiosyncratic DILI liability assessment, Expert Opinion on Drug Metabolism & Toxicology 21(7): 769-787.
- Bahtiri S., Hagens T.M.S., Water B. van de & Niemeijer M.C. (2025), Mechanism-based drug safety testing using innovative in vitro liver models: from DILI prediction to idiosyncratic DILI liability assessment, Expert Opinion on Drug Metabolism & Toxicology 21(7): 769-787.
- Niemeijer M.C., Danilyuk T.Y., Hagens T.M.S. Bahtiri S., Wijaya L.S., Davidse S.C., Kunnen S.J., Sinke L.J., Hochane M., Berk L. van den, Snijders K.E., Braak S.J. ter, Callegaro G., Le Dévédec S.E., Bouwman R.J.P. & Water B. van de (2025), Human hiPSC-derived hepatocyte-like cell stress response fluorescent protein reporter imaging platform for chemical screening, Toxicology Letters 411: 39.